Risk of cutaneous herpes zoster in patients with spondyloarthritis treated with conventional and biologic disease-modifying antirheumatic drugs.
Sabrina Ching Tung WongIris Wai Sum LiAlexandra Hoi Yan NgChak Sing LauHo Yin ChungPublished in: International journal of rheumatic diseases (2019)
Risk of cutaneous HZ in SpA was not lower than in RA. Methotrexate and infliximab were associated with cutaneous HZ in SpA.